探花精选

Ulrika Warpman Berglund

Affiliated to Research
Visiting address: Scilifelab, Alpha Building Level 4, Tomtebodav盲gen 23a, 17165 Solna
Postal address: K7 Onkologi-Patologi, K7 Forskning Helleday, 171 77 Stockholm
Part of:

About me

  • I received my PhD from Uppsala University in 1997 and was headhunted to
    Pharmacia and very soon became head of the Endocrine Research Group. During
    1997-2011 I was working in pharmaceutical companies both in Sweden
    (Pharmacia, Biovitrum) and UK (Prosidion Ltd), were I did translational
    research, developed clinical candidates, and obtained position as Director in
    Pharmacology and member of research steering groups. I joined Helleday lab in
    2012 and has since then assisted Prof. Helleday in establishing the
    translational team that exists today. As responsible for the MTH1 project, I
    have, together with the team, successfully developed Karonudib that is
    presently investigated in clinical trials. I am a member of Dept.
    Oncology-Pathology steering group and deputy group leader in the Helleday
    lab.

Research

  • Our lab is continuously working towards developing novel targeted therapies
    out of basic science findings. The multidisciplinary translational research
    group is focusing on understanding basic DNA repair and DNA-damage signaling
    pathways as well as nucleotide metabolism and developing novel drugs for
    anti-cancer treatments, and for treating inflammation/autoimmunity and virus
    infections.
    The research aims are to i) purifying and targeting proteins in *DNA repair
    and metabolism*, ii) use probes and genetic tools to increase basic knowledge
    around target proteins and iii) translating basic research findings into *new
    treatments *tested in clinic.
    One example how we taken an idea from bench to bedside:
    Many DNA damaging anti-cancer drugs cause replication-associated DNA damage
    that kill cancer cells. This is an effective way of treating cancer, but the
    problem is that also normal cells are damaged. Our strategy is to exploit the
    high level of DNA damage and dysfunctional redox status in cancer cells and
    prevent the repair of these lesions and even cause more oxidative lesions in
    the cancer cells. Using DNA repair inhibitors, we can selectively introduce
    toxic DNA damage to cancer cells. We demonstrated how targeting MTH1 can be
    used to target cancer in general without causing toxicity to non-transformed
    cells(Gad et al, Nature 2014; Huber et al., Nature 2014) and we have
    developed the MTH1 inhibitor (MTH1i) karonudib (*/Karo/*linska */NUD/*T1
    inh*/ib/*itor) (Warpman Berglund et al., Ann Oncol 2016) and progressed it
    through GMP manufacturing, formulation, GLP safety assessment, IMPD, Medical
    Product Agency and ethical approvals. Presently two clinical Phase 1 trials
    (one in patients with advanced solid malignancies and one in haematological
    cancers) with karonudib are on-going at Karolinska University Hospital.
    Pharmacology and biology are often more complex than originally thought, and
    we continue to deepen our understanding of the mechanism of action of our
    MTH1i and the role of MTH1 in cancer pathology.

Articles

  • Article: NATURE COMMUNICATIONS. 2025;16(1):1741
    Luttens A; Vo DD; Scaletti ER; Wiita E; Almlof I; Wallner O; Davies J; Kosenina S; Meng L; Long M; Mortusewicz O; Masuyer G; Ballante F; Michel M; Homan E; Scobie M; Kalderen C; Berglund UW; Tarnovskiy AV; Radchenko DS; Moroz YS; Kihlberg J; Stenmark P; Helleday T; Carlsson J
  • Article: MOLECULAR ONCOLOGY. 2024;18(9):2179-2195
    Marttila P; Bonagas N; Chalkiadaki C; Stigsdotter H; Schelzig K; Shen J; Farhat CM; Hondema A; Albers J; Wiita E; Rasti A; Warpman Berglund U; Slipicevic A; Mortusewicz O; Helleday T
  • Article: ONCOGENESIS. 2024;13(1):17
    Shen J; Mancina EG; Chen S; Manolakou T; Gad H; Berglund UW; Sanjiv K; Helleday T
  • Article: JOURNAL OF TRANSLATIONAL MEDICINE. 2023;21(1):169
    Pateras IS; Williams C; Gianniou DD; Margetis AT; Avgeris M; Rousakis P; Legaki A-I; Mirtschink P; Zhang W; Panoutsopoulou K; Delis AD; Pagakis SN; Tang W; Ambs S; Berglund UW; Helleday T; Varvarigou A; Chatzigeorgiou A; Nordstrom A; Tsitsilonis OE; Trougakos IP; Gilthorpe JD; Frisan T
  • Journal article: CHEMMEDCHEM. 2023;18(1)
    Wallner O; C谩zares鈥怟枚rner A; Scaletti ER; Masuyer G; Bekkhus T; Visnes T; Mamonov K; Ortis F; Lundb盲ck T; Volkova M; Koolmeister T; Wiita E; Loseva O; Pandey M; Homan E; Ben铆tez鈥怋uelga C; Davies J; Scobie M; Berglund UW; Kalder茅n C; Stenmark P; Helleday T; Michel M
  • Article: CHEMMEDCHEM. 2023;18(1):e202200310
    Wallner O; Cazares-Korner A; Scaletti ER; Masuyer G; Bekkhus T; Visnes T; Mamonov K; Ortis F; Lundback T; Volkova M; Koolmeister T; Wiita E; Loseva O; Pandey M; Homan E; Benitez-Buelga C; Davies J; Scobie M; Berglund UW; Kalderen C; Stenmark P; Helleday T; Michel M
  • Article: BIOMOLECULES. 2022;12(12):1777
    Henriksson S; Calderon-Montano JM; Solvie D; Berglund UW; Helleday T
  • Article: SCIENCE. 2022;376(6600):1471-1476
    Michel M; Ben铆tez-Buelga C; Calvo PA; Hanna BMF; Mortusewicz O; Masuyer G; Davies J; Wallner O; Sanjiv K; Albers JJ; Casta帽eda-Zegarra S; Jemth A-S; Visnes T; Sastre-Perona A; Danda AN; Homan EJ; Marimuthu K; Zhenjun Z; Chi CN; Sarno A; Wiita E; von Nicolai C; Komor AJ; Rajagopal V; M眉ller S; Hank EC; Varga M; Scaletti ER; Pandey M; Karsten S; Haslene-Hox H; Loevenich S; Marttila P; Rasti A; Mamonov K; Ortis F; Sch枚mberg F; Loseva O; Stewart J; D'Arcy-Evans N; Koolmeister T; Henriksson M; Michel D; de Ory A; Acero L; Calvete O; Scobie M; Hertweck C; Vilotijevic I; Kalder茅n C; Osorio A; Perona R; Stolz A; Stenmark P; Berglund UW; de Vega M; Helleday T
  • Article: MOLECULAR CANCER THERAPEUTICS. 2022;21(5):703-714
    Centio A; Estruch M; Reckzeh K; Sanjiv K; Vittori C; Engelhard S; Berglund UW; Helleday T; Theilgaard-Monch K
  • Article: NATURE CANCER. 2022;3(2):156-172
    Bonagas N; Gustafsson NMS; Henriksson M; Marttila P; Gustafsson R; Wiita E; Borhade S; Green AC; Vallin KSA; Sarno A; Svensson R; Gokturk C; Pham T; Jemth A-S; Loseva O; Cookson V; Kiweler N; Sandberg L; Rasti A; Unterlass JE; Haraldsson M; Andersson Y; Scaletti ER; Bengtsson C; Paulin CBJ; Sanjiv K; Abdurakhmanov E; Pudelko L; Kunz B; Desroses M; Iliev P; Farnegardh K; Kramer A; Garg N; Michel M; Haggblad S; Jarvius M; Kalderen C; Jensen AB; Almlof I; Karsten S; Zhang SM; Haggblad M; Eriksson A; Liu J; Glinghammar B; Nekhotiaeva N; Klingegard F; Koolmeister T; Martens U; Llona-Minguez S; Moulson R; Nordstrom H; Parrow V; Dahllund L; Sjoberg B; Vargas IL; Vo DD; Wannberg J; Knapp S; Krokan HE; Arvidsson PI; Scobie M; Meiser J; Stenmark P; Berglund UW; Homan EJ; Helleday T
  • Article: CELL DEATH AND DIFFERENTIATION. 2022;29(1):246-261
    Karsten S; Fiskesund R; Zhang X-M; Marttila P; Sanjiv K; Pham T; Rasti A; Br盲utigam L; Alml枚f I; Marcusson-St氓hl M; Sandman C; Platzack B; Harris RA; Kalder茅n C; Cederbrant K; Helleday T; Warpman Berglund U
  • Article: CELL CHEMICAL BIOLOGY. 2021;28(12):1693-1702.e6
    Zhang SM; Rehling D; Jemth A-S; Throup A; Landazuri N; Almlof I; Gottmann M; Valerie NCK; Borhade SR; Wakchaure P; Page BDG; Desroses M; Homan EJ; Scobie M; Rudd SG; Berglund UW; Soderberg-Naucler C; Stenmark P; Helleday T
  • Article: CANCER RESEARCH. 2021;81(22):5733-5744
    Sanjiv K; Calderon-Montano JM; Pham TM; Erkers T; Tsuber V; Almlof I; Hoglund A; Heshmati Y; Seashore-Ludlow B; Danda AN; Gad H; Wiita E; Gokturk C; Rasti A; Friedrich S; Centio A; Estruch M; Vatsveen TK; Struyf N; Visnes T; Scobie M; Koolmeister T; Henriksson M; Wallner O; Sandvall T; Lehmann S; Theilgaard-Monch K; Garnett MJ; Ostling P; Walfridsson J; Helleday T; Berglund UW
  • Article: BMC BIOLOGY. 2021;19(1):156
    Rietdijk J; Tampere M; Pettke A; Georgiev P; Lapins M; Warpman-Berglund U; Spjuth O; Puumalainen M-R; Carreras-Puigvert J
  • Article: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2021;141(8):2037-2048.e4
    Eding CB; Kohler I; Verma D; Sjogren F; Bamberg C; Karsten S; Pham T; Scobie M; Helleday T; Berglund UW; Enerback C
  • Article: CANCER RESEARCH. 2021;81(15):4079-4093
    Zhao Z; Gad H; Benitez-Buelga C; Sanjiv K; Hua X; Kang H; Feng M; Zhao Z; Berglund UW; Xia Q; Helleday T
  • Article: SCIENTIFIC REPORTS. 2021;11(1):6317
    Oksvold MP; Berglund UW; Gad H; Bai B; Stokke T; Rein ID; Pham T; Sanjiv K; Oy GF; Norum JH; Smeland EB; Myklebust JH; Helleday T; Vatsveen TK
  • Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2021;296:100568
    Rehling D; Zhang SM; Jemth A-S; Koolmeister T; Throup A; Wallner O; Scaletti E; Moriyama T; Nishii R; Davies J; Desroses M; Rudd SG; Scobie M; Homan E; Berglund UW; Yang JJ; Helleday T; Stenmark P
  • Article: VIRUSES-BASEL. 2020;13(1):E37-37
    Pettke A; Tampere M; Pronk R; Wallner O; Falk A; Warpman Berglund U; Helleday T; Mirazimi A; Puumalainen M-R
  • Article: VIRUSES-BASEL. 2020;12(12):E1423-1423
    Tampere M; Pettke A; Salata C; Wallner O; Koolmeister T; Cazares-Korner A; Visnes T; Hesselman MC; Kunold E; Wiita E; Kalderen C; Lightowler M; Jemth A-S; Lehtio J; Rosenquist A; Warpman-Berglund U; Helleday T; Mirazimi A; Jafari R; Puumalainen M-R
  • Show more

All other publications

  • Meeting abstract: BLOOD. 2024;144:6010
    Deneberg S; Uggla B; Smith A; Sandvall T; Klockare M; Breuer O; Berglund UW; Helleday T
  • Conference publication: 2023;:pa1247
    Ekstedt S; Kalderen C; Warpman Berglund U
  • Preprint: PREPRINTS.ORG. 2022
    Henriksson S; Calder贸n-Monta帽o JM; Solvie D; Warpman Berglund U; Helleday T
  • Editorial comment: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 2022;142(3 PT A):736-740.e6
    Das I; Tuominen R; Helleday T; Hansson J; Berglund UW; Brage SE
  • Preprint: CHEMRXIV. 2021
    Wallner O; C谩zares-K枚rner A; Scaletti ER; Masuyer G; Bekkhus T; Visnes T; Mamonov K; Ortis F; Lundb盲ck T; Volkova M; Koolmeister T; Wiita E; Loseva O; Pandey M; Homan E; Ben铆tez-Buelga C; Davies J; Scobie M; Warpman Berglund U; Kalder茅n C; Stenmark P; Helleday T; Michel M
  • Conference publication: 2021;:9227
    Gad H; Zhenjun Z; Benitez-Buelga C; Sanjiv K; Xiangwei H; Kang H; Mingxuan F; Zhicong Z; Warpman Berglund U; Qiang X; Helleday T
  • Meeting abstract: BLOOD. 2020;136:18-19
    Oksvold MP; Berglund UW; Gad H; Bai B; Stokke T; Rein ID; Pham T; Sanjiv K; Oy GF; Norum JH; Smeland EB; Myklebust JH; Helleday T; Vatsveen TK
  • Corrigendum: ONCOTARGET. 2020;11(8):827
    Pudelko L; Rouhi P; Sanjiv K; Gad H; Kalder茅n C; H枚glund A; Squatrito M; Schuhmacher AJ; Edwards S; H盲gerstrand D; Berglund UW; Helleday T; Br盲utigam L
  • Corrigendum: CELL DEATH & DISEASE. 2020;11(2):99
    Einarsdottir BO; Karlsson J; S枚derberg EMV; Lindberg MF; Funck-Brentano E; Jespersen H; Brynjolfsson SF; Bagge RO; Carstam L; Scobie M; Koolmeister T; Wallner O; Stierner U; Berglund UW; Ny L; Nilsson LM; Larsson E; Helleday T; Nilsson JA
  • Corrigendum: JOURNAL OF MEDICINAL CHEMISTRY. 2017;60(17):7614
    Llona-Minguez S; Hoglund A; Ghassemian A; Desroses M; Calderon-Montano JM; Moron EB; Valerie NCK; Wiita E; Almlof I; Koolmeister T; Mateus A; Cazares-Korner C; Sanjiv K; Homan E; Loseva O; Baranczewski P; Darabi M; Mehdizadeh A; Fayezi S; Jemth A-S; Berglund UW; Sigmundsson K; Lundback T; Jensen AJ; Artursson P; Scobie M; Helleday T
  • Meeting abstract: EUROPEAN JOURNAL OF CANCER. 2014;50:s87
    Braeutigam L; Fiskesund R; Warpman-Berglund U; Helleday T

News from KI

Events from KI